[ad_1]
Amneal Pharmaceuticals AMRX reported its Q2 earnings results on Friday, August 5, 2022 at 06:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Amneal Pharmaceuticals missed estimated earnings by 5.0%, reporting an EPS of $0.19 versus an estimate of $0.2.
Revenue was up $24.28 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 4.83% drop in the share price the next day.
Here’s a look at Amneal Pharmaceuticals’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.13 | 0.20 | 0.20 | 0.19 |
| EPS Actual | 0.12 | 0.18 | 0.21 | 0.25 |
| Revenue Estimate | 503.97M | 537.35M | 545.06M | 523.25M |
| Revenue Actual | 497.63M | 536.90M | 528.59M | 535.08M |
To track all earnings releases for Amneal Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.